Trial Outcomes & Findings for Multicenter Continuous Peripheral Nerve Block Surveillance Study (NCT NCT00653133)
NCT ID: NCT00653133
Last Updated: 2018-10-02
Results Overview
Adverse events related to performance of peripheral nerve catheter placement for continuous infusion of local anesthetic
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
1821 participants
Primary outcome timeframe
Preoperative through 3 days post operative
Results posted on
2018-10-02
Participant Flow
Participant milestones
| Measure |
USPNB
ultrasound imaging guided peripheral nerve block
|
NSPNB
Stimulator guided nerve block
|
|---|---|---|
|
Overall Study
STARTED
|
1324
|
497
|
|
Overall Study
COMPLETED
|
1324
|
497
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Multicenter Continuous Peripheral Nerve Block Surveillance Study
Baseline characteristics by cohort
| Measure |
USPNB
n=1324 Participants
ultrasound imaging guided peripheral nerve block
|
NSPNB
n=497 Participants
Stimulator guided nerve block
|
Total
n=1821 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
12 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
12 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
843 Participants
n=5 Participants
|
306 Participants
n=7 Participants
|
1149 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
469 Participants
n=5 Participants
|
191 Participants
n=7 Participants
|
660 Participants
n=5 Participants
|
|
Age, Continuous
|
57.1 years
STANDARD_DEVIATION 16.4 • n=5 Participants
|
57.7 years
STANDARD_DEVIATION 17.2 • n=7 Participants
|
57.3 years
STANDARD_DEVIATION 16.6 • n=5 Participants
|
|
Sex: Female, Male
Female
|
649 Participants
n=5 Participants
|
214 Participants
n=7 Participants
|
863 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
675 Participants
n=5 Participants
|
283 Participants
n=7 Participants
|
958 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
1324 participants
n=5 Participants
|
497 participants
n=7 Participants
|
1821 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Preoperative through 3 days post operativePopulation: Intent to treat (ITT)
Adverse events related to performance of peripheral nerve catheter placement for continuous infusion of local anesthetic
Outcome measures
| Measure |
USPNB
n=1324 Participants
Ultrasound imaging guided peripheral nerve block
|
NSPNB
n=497 Participants
Nerve Stimulator guided peripheral nerve block
|
|---|---|---|
|
Complications of Peripheral Nerve Block
|
7 participants
|
14 participants
|
Adverse Events
USPNB
Serious events: 0 serious events
Other events: 7 other events
Deaths: 0 deaths
NSPNB
Serious events: 0 serious events
Other events: 14 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
USPNB
n=1324 participants at risk
ultrasound imaging guided peripheral nerve block
|
NSPNB
n=497 participants at risk
Stimulator guided nerve block
|
|---|---|---|
|
Vascular disorders
VASCULAR PUNCTURE
|
0.30%
4/1324 • Number of events 4 • 7 days postoperative
|
1.6%
8/497 • Number of events 8 • 7 days postoperative
|
|
Infections and infestations
Infection
|
0.15%
2/1324 • Number of events 2 • 7 days postoperative
|
0.40%
2/497 • Number of events 2 • 7 days postoperative
|
|
Nervous system disorders
motor block
|
0.08%
1/1324 • Number of events 1 • 7 days postoperative
|
0.80%
4/497 • Number of events 4 • 7 days postoperative
|
Additional Information
Alan Dine Director of Clinical Research
I-Flow Corporation
Phone: 513-253-8033
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place